Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC β-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae

被引:21
作者
Lee, K
Hong, SG
Park, YJ
Lee, HS
Song, W
Jeong, J
Yong, D
Chong, Y [1 ]
机构
[1] Yonsei Univ Hosp, Dept Lab Med, Seoul 120752, South Korea
[2] Pundang CHA Univ Hosp, Dept Lab Med, Sungnam 463712, South Korea
[3] Catholic Univ Hosp, Dept Lab Med, Seoul 137040, South Korea
[4] Chonbuk Natl Univ Hosp, Dept Lab Med, Chonju 561712, South Korea
[5] Hallym Univ, Sacred Heart Hosp, Dept Lab Med, Seoul 150071, South Korea
[6] Univ Ulsan Hosp, Dept Lab Med, Ulsan 682714, South Korea
关键词
AmpC beta-lactamase; Cefoxitin-Hodge test; induction test;
D O I
10.1016/j.diagmicrobio.2005.07.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Detection of plasmid-mediated (P-M) AmpC beta-lactamase-producing isolates is considered critical for epidemiologic studies and hospital infection control, but the documents of the Clinical and Laboratory Standards Institute do not contain any recommendation for the phenotypic detection, In this study, phenotypic detection methods, cefoxitin-Hodge test and induction test, were evaluated using cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae isolates. The cefoxitin-Hodge test detected all bla(CMY-10), and 97.4% of bla(CMY-2) allele-positive isolates, but only 57.3% of bla(DHA-1) allele-positive isolates. Induction test with an aztreonam and an amoxicillin-clavulanic acid disk was more sensitive than with cefoxitin disk, which detected 86.6% of bla(CMY-2) allele-positive isolates. These phenotypic tests should be useful to screen beta-M AmpC beta-lactamase-producing E. coli and K. pneumoniae isolates. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:319 / 323
页数:5
相关论文
共 20 条
[1]   Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States [J].
Alvarez, M ;
Tran, JH ;
Chow, N ;
Jacoby, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :533-537
[2]   EXTENDED BROAD-SPECTRUM BETA-LACTAMASE IN KLEBSIELLA PNEUMONIAE INCLUDING RESISTANCE TO CEPHAMYCINS [J].
BAUERNFEIND, A ;
CHONG, Y ;
SCHWEIGHART, S .
INFECTION, 1989, 17 (05) :316-321
[3]  
Clinical and Laboratory Standards Institute, 2005, M100S15 NCCLS CLIN L
[4]  
COURDRON PE, 2000, J CLIN MICROBIOL, V38, P1791
[5]  
FARMER JJIII, 2003, AM SOC MICROBIOL, P636
[6]   AmpC β-lactamases:: what do we need to know for the future? [J].
Hanson, ND .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) :2-4
[7]   Antimicrobial activity of broad-spectrum agents tested against Gramnegative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001) [J].
Jones, RN ;
Varnam, DJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 44 (04) :379-382
[8]   Emergence of multidrug-resistant Salmonella enterica serovar Typhi in Korea [J].
Lee, K ;
Yong, D ;
Yum, JH ;
Lim, YS ;
Kim, HS ;
Lee, BK ;
Chong, YS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) :4130-4135
[9]   Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. [J].
Lee, K ;
Lim, YS ;
Yong, D ;
Yum, JH ;
Chong, Y .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) :4623-4629
[10]  
Livermore D.M., 1996, ANTIBIOTICS LAB MED, P502